Insiders who reported open-market trades in the last 12 months at the companies Weiss Asset Management LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Eli Samaha - $5.91M in TBPH purchases and sales in the last 12 months
Eran Broshy - $1.66M in TBPH purchases and sales in the last 12 months
Rhonda Farnum - $1.46M in TBPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Weiss Asset Management LP is an investment firm of Theravance Biopharma, Inc. (TBPH). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Weiss Asset Management LP submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Weiss Asset Management LP been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($233.35M) across all tracked filings.
Weiss Asset Management LP files SEC Form 4 reports at Theravance Biopharma, Inc. (TBPH). 2 SEC Form 4 filings on record, most recently on 28 September 2026. Most recent open-market trade: sold $233.35M of AVDL on 18 February 2026. Lifetime open-market sales: $233.35M.
Recent transactions
2
The latest 2 SEC Form 4 transactions reported by Weiss Asset Management LP.
InsiderAlpha's records for Weiss Asset Management LP go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
